SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TECHNE (Tech): "selling picks to gold miners" -- Ignore unavailable to you. Want to Upgrade?


To: Joe Dancy who wrote (10)1/23/1999 1:35:00 AM
From: Shane M  Read Replies (1) | Respond to of 47
 
Joe,

Thing with BIOI is the execution doesn't seem to be there. I first looked into BIOI after running into you on a SFLX board I think over a year ago, and everyone was talking about potential for BIOI then. Disappointment has continued to rule the day. Whether it's currency translation, need of new CFO, inventory writedown, slow revenue growth, etc, BIOI has consistently found a way to disappoint. Perhaps things are starting to turn around at BIOI and I should give it another look. I had pretty much thrown in the towel. You're right, it continues to look cheap - but is there a catalyst to get it moving?

Another thing: when companies can grow through acquisition, a highly valued stock is an enabler. Competitively, this hurts BIOI and helps TECH.

I enjoy the Lone Star Growth Investor. Good luck,

Shane



To: Joe Dancy who wrote (10)2/24/1999 2:46:00 PM
From: Walter Morton  Respond to of 47
 
Now that TECH has bought CIST only product with a market, should CIST shareholders dump and run?